Francesca Nardecchia

908 total citations
46 papers, 506 citations indexed

About

Francesca Nardecchia is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Francesca Nardecchia has authored 46 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Clinical Biochemistry and 14 papers in Physiology. Recurrent topics in Francesca Nardecchia's work include Metabolism and Genetic Disorders (27 papers), Mitochondrial Function and Pathology (18 papers) and Diet and metabolism studies (11 papers). Francesca Nardecchia is often cited by papers focused on Metabolism and Genetic Disorders (27 papers), Mitochondrial Function and Pathology (18 papers) and Diet and metabolism studies (11 papers). Francesca Nardecchia collaborates with scholars based in Italy, United Kingdom and Germany. Francesca Nardecchia's co-authors include Vincenzo Leuzzi, Filippo Manti, Claudia Carducci, Flavia Chiarotti, Carla Carducci, Serena Galosi, Sabrina Leo, Danique van Vliet, Francjan J. van Spronsen and Cristina Romani and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Lipid Research and Nutrients.

In The Last Decade

Francesca Nardecchia

39 papers receiving 501 citations

Peers

Francesca Nardecchia
Tessa Wassenberg Netherlands
Kristin Barañano United States
Zwi H. Hart United States
Dora Steel United Kingdom
Anne Koy Germany
Ingrid Degen Germany
Francesca Nardecchia
Citations per year, relative to Francesca Nardecchia Francesca Nardecchia (= 1×) peers Alfonso Oyarzábal

Countries citing papers authored by Francesca Nardecchia

Since Specialization
Citations

This map shows the geographic impact of Francesca Nardecchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Nardecchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Nardecchia more than expected).

Fields of papers citing papers by Francesca Nardecchia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Nardecchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Nardecchia. The network helps show where Francesca Nardecchia may publish in the future.

Co-authorship network of co-authors of Francesca Nardecchia

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Nardecchia. A scholar is included among the top collaborators of Francesca Nardecchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Nardecchia. Francesca Nardecchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biagiotti, Sara, Francesca Nardecchia, Luigia Rossi, et al.. (2025). GAMT Deficiency: Clinical Presentation, Treatment, Diagnosis, Animal Models, Preclinical and Clinical Developments. International Journal of Molecular Sciences. 26(23). 11282–11282.
2.
Manti, Filippo, Silvia Santagata, Antonio Angeloni, et al.. (2025). The clinical value of peripheral biogenic amine metabolites in early-treated phenylketonuria. Molecular Genetics and Metabolism. 145(1). 109088–109088.
3.
Nardecchia, Francesca, Gerarda Cappuccio, S. Rahman, et al.. (2025). Deletion Testing of the DEGS1 Gene Should Be Part of the Diagnostic Pipeline for Hypomyelinating Leukodystrophy (HLD18). Human Mutation. 2025(1). 3531508–3531508.
4.
Nardecchia, Francesca, Claudia Carducci, Mario Mastrangelo, et al.. (2025). The value of CSF neurotransmitter monitoring in the outcome of gene therapy in aromatic amino acid decarboxylase (AADC) defect. Parkinsonism & Related Disorders. 136. 107886–107886.
5.
Galosi, Serena, Cecilia Mancini, Paolo Calligari, et al.. (2024). Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome. Movement Disorders. 39(7). 1225–1231. 2 indexed citations
6.
Dei, Michele, Anna Caretti, Carla Martinelli, et al.. (2024). Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism. Journal of Lipid Research. 65(3). 100517–100517. 1 indexed citations
7.
Scala, Iris, Lucia Brodosi, Filippo Manti, et al.. (2024). Pegvaliase therapy for phenylketonuria: Real-world case series and clinical insights. Molecular Genetics and Metabolism. 142(1). 108151–108151. 3 indexed citations
8.
Baglioni, Valentina, et al.. (2024). Psychiatric Manifestations in Children and Adolescents with Inherited Metabolic Diseases. Journal of Clinical Medicine. 13(8). 2190–2190. 2 indexed citations
9.
Galosi, Serena, Giovanna Zorzi, Simone Martinelli, et al.. (2023). GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments. Parkinsonism & Related Disorders. 111. 105405–105405. 17 indexed citations
10.
Manti, Filippo, Francesca Nardecchia, Sabrina Leo, et al.. (2023). Towards precision medicine for phenylketonuria: The effect of restoring a strict metabolic control in adult patients with early-treated phenylketonuria. Molecular Genetics and Metabolism. 140(3). 107666–107666. 6 indexed citations
11.
Bianchi, Marzia, Luigia Rossi, Francesca Pierigè, et al.. (2022). Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine. Molecular Therapy — Methods & Clinical Development. 25. 26–40. 1 indexed citations
12.
Galosi, Serena, et al.. (2022). Fever‐Induced and Early Morning Paroxysmal Dyskinesia in a Man With GNB1 Encephalopathy. Movement Disorders Clinical Practice. 9(S2). S41–S43. 4 indexed citations
13.
Salviati, Leonardo, Vincenzo Leuzzi, Anna Rubegni, et al.. (2021). New pathogenic variants in COQ4 cause ataxia and neurodevelopmental disorder without detectable CoQ10 deficiency in muscle or skin fibroblasts. Journal of Neurology. 268(9). 3381–3389. 18 indexed citations
14.
Nardecchia, Francesca, et al.. (2020). Multiple sclerosis and intracellular cobalamin defect (MMACHC/PRDX1) comorbidity in a young male. Molecular Genetics and Metabolism Reports. 22. 100560–100560. 4 indexed citations
15.
Romani, Cristina, Filippo Manti, Francesca Nardecchia, et al.. (2019). Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels. Orphanet Journal of Rare Diseases. 14(1). 273–273. 36 indexed citations
16.
Nardecchia, Francesca, Rosamaria Orlando, Luisa Iacovelli, et al.. (2018). Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria. Frontiers in Neuroscience. 12. 154–154. 12 indexed citations
17.
Nardecchia, Francesca, Flavia Chiarotti, Claudia Carducci, et al.. (2017). Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency. European Journal of Pediatrics. 176(7). 917–924. 1 indexed citations
18.
Nardecchia, Francesca, Filippo Manti, Flavia Chiarotti, et al.. (2015). Neurocognitive and neuroimaging outcome of early treated young adult PKU patients: A longitudinal study. Molecular Genetics and Metabolism. 115(2-3). 84–90. 57 indexed citations
19.
Mastrangelo, Mario, Flavia Chiarotti, Claudia Carducci, et al.. (2015). The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Molecular Genetics and Metabolism. 116(3). 171–177. 28 indexed citations
20.
Papetti, Laura, Pasquale Parisi, Vincenzo Leuzzi, et al.. (2012). Metabolic epilepsy: An update. Brain and Development. 35(9). 827–841. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026